EUVIMEDOpdag EUVIMED
Crossref

Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values

Ivan Rogic, Anja Tea Golubic, Marijan Zuvic, Tea Smitran, Nino Jukic, Marija Gamulin, Zeljko Kastelan, Drazen Huic

Nuclear Medicine Review · 2024

DOI: 10.5603/nmr.97424 ↗

At a glance

Journal article in Nuclear Medicine Review, 2024. Written by Ivan Rogic and 7 co-authors. Institution: Clinical Department of Nuclear Medicine and Radiation Protection, University Hospital Centre Zagreb, Croatia. derogich@gmail.com. Major MEDLINE topics: Neoplasm Staging, Prostatic Neoplasms. Cited 6 times so far (Crossref).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

As in disease recurrence, providing clinicians with the exact extent of the disease at the time of initial diagnosis is key in the management and individual treatment of prostate cancer (PC) patients. Intending to examine the usefulness of gallium- 68 PSMA-11 positron emission tomography/computed tomography ([68Ga]Ga-PSMA-11 PET/CT) and to determine if there is a correlation between prostate-specific antigen (PSA) serum values, WHO/ISUP (World Health Organization/International Society of Urological Pathology’s) grade group of the tumor and SUVmax (maximized standardized uptake value) values we retrospectively analyzed PET/CT studies performed for initial staging of the disease. Patients and methods: We retrospectively evaluated 34 studies of patients who underwent [68Ga]Ga-PSMA-11 PET/CT as part of the initial staging of prostate cancer. All patients had prostate cancer confirmed by histological assessment after biopsy and had Gleason score and PSA serum values obtained. The mean PSA value was 33.8 ± 40.9 nmol/L (range 2.2–232).

Results

Nineteen patients had extended disease (55.9%). The mean SUVmax in prostate lesions was 19.5 ± 12.6. The mean value of SUVmax of PET studies in the high-risk group was significantly higher than those of low risk (23.5 ± 13.2 and 10.6 ± 5.4, p < 0.05). A positive correlation was observed between the ISUP group and SUVmax value of prostate lesions (Pearson’s r = 0.557, p < 0.01). A positive correlation was also found in the comparison between PSA values and SUVmax (Pearson’s r = 0.34, p < 0.05).

Conclusions

In our study, [68Ga]Ga-PSMA-11 PET/CT scans detected the extended disease in more than half of the patients. Locating disease beyond the prostate gland allowed better informed clinical decisions and modified treatment. A positive correlation was found between intraprostatic SUVmax values and the ISUP group of prostate cancer. High-risk patients had SUVmax values that were significantly higher than those of low-risk patients. The correlation between the Gleason score and SUVmax value can be explained by the increased intensity of PSMA expression as the tumor grade increases.

Subjects

MeSH terms (MEDLINE)

Neoplasm StagingProstatic NeoplasmsAgedAged, 80 and overHumansMaleMiddle AgedEdetic AcidGallium IsotopesGallium RadioisotopesOligopeptidesPositron Emission Tomography Computed TomographyProstate-Specific AntigenRetrospective Studies

Author keywords

ISUP grade groupsPSMA expressionPSMA/PET[68Ga]Ga-PSMA-11primary stagingprostate cancer stagingprostatic SUVmax values

Substances

Edetic Acidgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesOligopeptidesProstate-Specific AntigenPSMA-11

Authors and institutions

  • Clinical Department of Nuclear Medicine and Radiation Protection, University Hospital Centre Zagreb, Croatia. derogich@gmail.com.
  • Clinical Department of Nuclear Medicine and Radiation Protection, University Hospital Centre Zagreb, Croatia.
  • School of Medicine, Zagreb, Croatia.
  • Clinical Department of Oncology, University Hospital Centre Zagreb, Croatia.
  • Clinical Department of Urology, University Hospital Centre Zagreb, Croatia.

Cite

APA

Rogic, I., Golubic, A. T., Zuvic, M., Smitran, T., Jukic, N., Gamulin, M., Kastelan, Z., & Huic, D. (2024). Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values. Nuclear Medicine Review. https://doi.org/10.5603/nmr.97424

Vancouver

Rogic I, Golubic AT, Zuvic M, Smitran T, Jukic N, Gamulin M, et al. Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values. Nuclear Medicine Review. 2024. doi:10.5603/nmr.97424

BibTeX
@article{Rogic2024,
  author = {Rogic, Ivan and Golubic, Anja Tea and Zuvic, Marijan and Smitran, Tea and Jukic, Nino and Gamulin, Marija and Kastelan, Zeljko and Huic, Drazen},
  title = {Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values},
  journal = {Nuclear Medicine Review},
  year = {2024},
  doi = {10.5603/nmr.97424}
}
Start for free →